ETC Innovation develops next-generation wound dressing materials, antimicrobial substrates, and infection control products — integrating materials science, manufacturing capability, and regulatory readiness under one roof.
ETC Innovation specializes in process and product development of medical materials for bandages and infection control. We hold positions in four companies with unique patented devices and IP — PF Magic, DrySee, FiteBac WoundCare, and SubPac Wound Care — and invest in the materials science, manufacturing equipment, and regulatory compliance infrastructure to bring those products to market.
Our pipeline spans active wound dressings, wetness indication materials, infection control substrates, and novel antimicrobial delivery systems — each at a defined development and regulatory stage.
Traditionally, our customers are large medical brands or the converters and suppliers to these large brands. Projects take months to years and often result in custom materials with features for a market or branding advantage.
ETC Innovation is happy to partner and be your roll-goods supplier of custom materials developed and produced in the USA. Contact us to start a conversation.
We produce several grades of polyurethane foam for use in advanced wound care applications.
Absorption, Adsorption, Wicking, Gelling and Superabsorbent properties are all optimized for optimum wound healing. Wetness Indication provides vital information to the caregiver.
For over 25 years antimicrobial formulations have been studied, optimized and brought into production as wound care materials. Silver, CHG, PHMB, Quat silanes, etc.
Our USA-based manufacturing site houses pilot-scale and production-ready equipment, giving partners a direct path from formulation to compliant commercial output — with no change of custody. Our level of vertical integration is unheard of. We offer a start-to-finish solution to complex wound care devices.
ETC can provide sterile market-ready wound care products with your branding and packaging, 100% made in the USA with domestic materials. Our level of vertical integration allows us to be highly competitive with Asian options.
Our pilot line is designed to replicate production conditions at reduced scale, enabling rapid iteration and process validation before scale-up.
Our production line is capable of manufacturing finished, packaged, and labeled wound care devices at commercial volume, including our highly complex SubPac® subdermal dressing system.
The principals of ETC Innovation hold equity and have invested in four companies in closely related fields. Click any company to learn more.
Sublingual & Transdermal Delivery
Unique and customized formulations of rapidly dissolving sublingual tablets and extended release skin patches. Peptides, pain relief and more.
Equity Position · pfmagical.com
Subdermal Wound Dressing
The SubPac subdermal drainage system is novel and patented. It has demonstrated strong infection control performance in challenging surgeries and trauma. At ETC Innovation, SubPac has received several material and functionality updates, a new production system — and fresh FDA clearance will follow shortly.
Equity Holder · Manufacturer
Visit SubPacWoundCare.com →Wetness Indication Technology
Patented HydroChromatic indicator materials that change color upon moisture contact. ETC Innovation holds the exclusive manufacturing license — producing the indicator materials used in DrySee wound dressings and foam dressings.
Exclusive Manufacturing License
K21 Antimicrobial Molecule
K21 quaternary ammonium silane — FDA NME recognition, active NDA 128706, composition of matter patents in US, Europe, and China. Bactericidal, viricidal, fungicidal with biofilm inhibition.
Market Introduction Partner
Visit FiteBacWoundCare.com →Riverworks is our affiliated applied research entity — dedicated to long-horizon exploration of advanced materials, novel IP combinations, and emerging clinical applications. Ideas that originate at Riverworks feed directly into ETC Innovation's development pipeline.
Riverworks also conducts confidential development programs for small and large medical entities — spanning Material Science through Process Development and Integration. Please contact us for a confidential discussion and options.
Learn about Riverworks →Earlier production technology has been replaced with a custom robust 100% automated process. The materials have been optimized and will contain PHMB for superior infection control functionality. Check back for updates.
In conjunction, FiteBac and ETC Innovation anticipate a K21 + Foam dressing as the first product launch in the Advanced Wound Care space. Check back for updat